Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  General Hospital Psychiatry

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.genhosppsych.2010.03.001PMID 20633744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IFN-induced depression: a role for NSAIDs.

  2025influential reference
• A neuropsychological study comparing patients infected with HCV and HBV without psychiatric comorbidities

  2009cited by this paper
• Common skin cancers and their precursors.

  2009cited by this paper
• Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment

  2009cited by this paper
• Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.

  2009cited by this paper
• The effect of early virological response in health‐related quality of life in HCV‐infected patients

  2008cited by this paper
• Does antidepressant medication in patients with hepatitis C undergoing interferon α treatment reduce therapeutic efficacy?

  2008cited by this paper
• Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions.

  2008cited by this paper
• High frequency of unrecognized mental disorders in HCV-infected patients.

  2008cited by this paper
• Assessment of the PHQ-9 as a Screening Tool for Depression in Patients with Chronic Hepatitis C

  2008cited by this paper
• Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study

  2007cited by this paper
• Paroxetine for prevention of depressive symptoms induced by interferon‐alpha and ribavirin for hepatitis C

  2007cited by this paper
• Interferon-induced depression in hepatitis C: An update

  2007influential reference
• Preventing Relapse of Major Depression During Interferon-α Therapy for Hepatitis C—A Pilot Study

  2007influential reference
• Incidence of psychiatric side effects during pegylated interferon‐ α retreatment in nonresponder hepatitis C virus‐infected patients

  2007cited by this paper
• Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.

  2007cited by this paper
• Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.

  2007cited by this paper
• A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

  2007cited by this paper
• Effect of amantadine on depressive symptoms in chronic hepatitis C patients treated with pegylated interferon: a randomized, controlled pilot study.

  2006cited by this paper
• Psychiatric Morbidity and its Effect on the Quality of Life of Patients with Chronic Hepatitis B and Hepatitis C

  2006cited by this paper
• Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches

  2006cited by this paper
• Central nervous system changes in hepatitis C virus infection.

  2006cited by this paper
• Apomorphine: A Rapid Rescue Agent for the Management of Motor Fluctuations in Advanced Parkinson Disease

  2006cited by this paper
• Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

  2005cited by this paper
• Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.

  2005cited by this paper
• Prophylactic SSRI during interferon alpha re‐therapy in patients with chronic hepatitis C and a history of interferon‐induced depression

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Cytokines and psychopathology: lessons from interferon-alpha.

  2004cited by this paper
• Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.

  2003cited by this paper
• Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions

  2002cited by this paper
• A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C

  2002cited by this paper
• Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

  2002cited by this paper
• Letters of condolence.

  2001cited by this paper
• Letters of condolence.

  2001cited by this paper
• Letters of condolence.

  2001cited by this paper
• Paroxetine for the prevention of depression induced by high-dose interferon alfa.

  2001influential reference
• Paroxetine for the prevention of depression induced by interferon alfa.

  2001cited by this paper
• Prophylactic Treatment of Depression Induced by Interferon-α

  2000cited by this paper
• Prophylactic treatment of depression induced by interferon-alpha.

  2000cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.

  1997cited by this paper
• Effect of Interferon-α Treatment of Chronic Hepatitis C on Health-Related Quality of Life

  1997cited by this paper

• Factors associated with hepatitis C virus antibody positive in Korean : Based on the 5․6th Korea National Health and Nutrition Examination Survey

  2024cites this paper
• Melatonin prevented depressive-like behavior following cyclosporine A or interferon-α administration in mice

  2022cites this paper
• Vanillic acid prevents interferon-alpha and cyclosporine A-induced depressant-like behavior in mice

  2022cites this paper
• Depression and anxiety in patients receiving interferon-alpha: The role of illness perceptions

  2018cites this paper
• Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation

  2018cites this paper
• Deficits in temporal order memory induced by interferon-alpha (IFN-α) treatment are rescued by aerobic exercise.

  2018cites this paper
• Bacterial Lipopolysaccharide Increases Serotonin Metabolism in Both Medial Prefrontal Cortex and Nucleus Accumbens in Male Wild Type Rats, but Not in Serotonin Transporter Knockout Rats

  2018cites this paper
• Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications

  2016cites this paper
• Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis C

  2016cites this paper
• Psychological side-effects of immunotherapies in the treatment of malignant melanoma

  2016cites this paper
• Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients.

  2015cites this paper
• Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications.

  2015cites this paper
• Chronobiology, cognitive function and depressive symptoms in surgical patients.

  2014cites this paper
• Side Effects of Interferon Therapy in Adolescent Melanoma

  2014cites this paper
• Serotonin-1A receptor CC genotype is associated with persistent depression related to interferon-alpha in hepatitis C patients.

  2014cites this paper
• Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.

  2014cites this paper
• Effect of Melatonin on Cognitive Function and Sleep in relation to Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

  2014cites this paper
• Specific serotonin reuptake inhibitors prevent interferon-α-induced depression in patients with hepatitis C: a meta-analysis.

  2014cites this paper
• Psychological Changes in Melanoma Patients During Ipilimumab Treatment Compared to Low-Dose Interferon Alpha Therapy—A Follow-Up Study of First Experiences

  2014cites this paper
• Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways.

  2014cites this paper
• Longitudinal Effects of Selective Serotonin Reuptake Inhibitor Therapy and Cytokine-Related Depression on Hepatitis C Viral Logs During Antiviral Therapy

  2014cites this paper
• BREAST CANCER , CIRCADIAN DISRUPTION , MOOD DISORDERS AND SYMPTOMS CLUSTERS Symptom clusters

  2014cites this paper
• Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.

  2014cites this paper
• Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.

  2014cites this paper
• Interferon-induced depression in patients with hepatitis C: an epidemiologic study.

  2014cites this paper
• Prescription Opioid Analgesics Increase Risk of Major Depression: New Evidence, Plausible Neurobiological Mechanisms and Management to Achieve Depression Prophylaxis.

  2014cites this paper
• The Depression Predictors among Patients with Peg-interferon Treated Hepatitis C

  2014cites this paper
• Inflammation-induced depression : Studying the role of proinflammatory cytokines in anhedonia

  2014cites this paper
• An Inflammatory Perspective of Stress and Human Depressive Disorder

  2013cites this paper
• Self‐efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression

  2013cites this paper
• Strategies for Treating Depression in Patients with Hepatitis C: Psychiatric Symptoms Can Precede Infection or Be Caused by HCV Treatments

  2013cites this paper
• [Psycho-organic diseases in children and adolescents affected by pediatric neoplasms].

  2013cites this paper
• When do psychiatric side effects emerge during antiviral treatment of hepatitis C?

  2013cites this paper
• Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study.

  2013cites this paper
• Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection

  2012cites this paper
• Assessing Psychiatric Adverse Effects during Clinical Drug Development

  2012cites this paper
• The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update

  2012cites this paper
• Understanding clinical risk decision making regarding development of depression during interferon-alpha treatment for hepatitis-C: a qualitative interview study.

  2012cites this paper
• [Depression in patients with chronic hepatitis C during the antiviral treatment: a clinical and psychopathological qualification and a nosological interpretation].

  2012cites this paper
• Prospective study of psychiatric side effects during antiviral therapy of chronic hepatitis C in an Egyptian sample

  2012cites this paper
• Hepatitis C treatment and erotomania.

  2012cites this paper
• Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.

  2011cites this paper
• Is the interferon-α-triggered depressive episode a self-limited kind of depression? Four cases of persistent affective symptoms after antiviral treatment in HCV-infected individuals

  2010cites this paper